Scanogen is a molecular diagnostic company developing a system to provide rapid and easy access to the biomolecular information of body fluids with the goal of improving health care. The Company has developed Single MOLecule Tethering (SMOLT), a proprietary technology for rapid and ultra-sensitive detection of biomolecules. The Company is using this technology to develop a simple-to-use and sample-to-answer diagnostic platform. Scanogen has received NIH grants totaling more than $20 million to develop its diagnostic assays and is currently focused on developing a suite of point-of-care tests which use rapid assays to diagnose bloodstream infections.
The company is located in Baltimore, Maryland. This location allows for collaboration with Johns Hopkins University and with government agencies in Washington D.C (FDA, NIH, NIST).
Read Scanogen FCOI Policy.